These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 26913593

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
    Takeuchi M, Yano I, Ito S, Sugimoto M, Yamamoto S, Yonezawa A, Ikeda A, Matsubara K.
    Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
    [Abstract] [Full Text] [Related]

  • 3. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
    Toublanc N, Sargentini-Maier ML, Lacroix B, Jacqmin P, Stockis A.
    Clin Pharmacokinet; 2008 Apr; 47(5):333-41. PubMed ID: 18399714
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
    Rhee SJ, Shin JW, Lee S, Moon J, Kim TJ, Jung KY, Park KI, Lee ST, Jung KH, Yu KS, Jang IJ, Chu K, Lee SK.
    Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S, Jullien V, Rey E, Dulac O, Chiron C, Pons G.
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS.
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of an integrated population pharmacokinetic model for oral levetiracetam in populations of various ages and ethnicities.
    Toublanc N, Lacroix BD, Yamamoto J.
    Drug Metab Pharmacokinet; 2014 Apr; 29(1):61-8. PubMed ID: 23877106
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Age and comedications influence levetiracetam pharmacokinetics in children.
    Dahlin MG, Wide K, Ohman I.
    Pediatr Neurol; 2010 Oct; 43(4):231-5. PubMed ID: 20837299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictive Performance of Population Pharmacokinetic Models of Levetiracetam in Children and Evaluation of Dosing Regimen.
    Tauzin M, Tréluyer JM, Nabbout R, Chemaly N, Billette de Villemeur T, Desguerre I, Lui G, Gana I, Boujaafar S, Zheng Y, Benaboud S, Bouazza N, Chenevier-Gobeaux C, Freihuber C, Hirt D.
    J Clin Pharmacol; 2021 Oct; 61(10):1366-1375. PubMed ID: 33997989
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.